Evolution of sarcopenia status and risk of incident cardiovascular disease
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Changes in sarcopenia status significantly impact cardiovascular disease (CVD) risk. Developing sarcopenia increases CVD risk, while recovering from sarcopenia lowers it, highlighting the importance of monitoring muscle health for heart disease prevention.
Area Of Science
- Gerontology
- Cardiovascular Medicine
- Muscle Physiology
Background
- Sarcopenia, an age-related loss of muscle mass and strength, is increasingly recognized as a risk factor for cardiovascular disease (CVD).
- Previous research has not fully explored the dynamic relationship between changes in sarcopenia status and the development of CVD.
- Understanding these changes is crucial for identifying individuals at higher risk and developing targeted interventions.
Purpose Of The Study
- To investigate the association between changes in sarcopenia status and the incidence of cardiovascular disease (CVD).
- To determine if the progression or recovery of sarcopenia influences CVD risk.
- To establish a causal link between sarcopenia status changes and CVD using robust analytical methods.
Main Methods
- Analysis of two large prospective cohorts: the China Health and Retirement Longitudinal Study (CHARLS) and the Health and Retirement Study (HRS).
- Assessment of changes in sarcopenia status based on initial survey data.
- Ascertainment of incident cardiovascular disease (CVD) through self-reported physician diagnoses of heart disease or stroke.
Main Results
- Meta-analysis confirmed a significant relationship between sarcopenia and increased CVD risk.
- Bidirectional Mendelian randomization (MR) analysis supported a causal link from sarcopenia to CVD, with no evidence of reverse causation.
- Progression to sarcopenia was associated with a higher incidence of CVD (IRR 1.29-1.39), while recovery from sarcopenia significantly reduced CVD incidence (IRR 0.20-0.61).
Conclusions
- The progression of sarcopenia status is a significant risk factor for developing cardiovascular disease.
- Recovery from sarcopenia status is associated with a reduced risk of incident cardiovascular disease.
- These findings underscore the dynamic interplay between muscle health and cardiovascular outcomes, suggesting potential therapeutic targets.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...